Milking the Umbilical Cord for Extreme Preterm Infants

Sponsor
St. Louis University (Other)
Overall Status
Completed
CT.gov ID
NCT01666847
Collaborator
(none)
59
2
2
57
29.5
0.5

Study Details

Study Description

Brief Summary

Milking the umbilical cord from the placental end toward the infant has been shown to benefit preterm infants when compared to either clamping the umbilical cord immediately or waiting delaying the clamping of the cord. Delaying cord clamping for 30-120 seconds has been shown to improve heart and lung function, reduces the need for blood transfusion, and reduces the risk for brain bleeding seen in some preterm infants. Delaying the clamping of the umbilical cord, however in extremely premature infants is not considered safe, since it also delays the resuscitation that these infants need immediately after birth. Milking the umbilical cord is believed have similar benefits to delaying the clamping of the cord, but can be done much faster (seconds rather than minutes). In this study, the cord will milked three times over about 10-20 seconds and the infant will be passed to the awaiting newborn medical team for routine care. Participants of this study will be randomly assigned to one of two study groups: the first group will have the cord milking intervention and the second group will not have any intervention other than routine, immediate cord clamping with routine care of mother and infant. Data will be collected about the mother prior to delivery and data will also be collected about the baby using computerized health records. The data will look at short term changes in red blood cell volumes, the need for blood transfusions, and rates of known complications of prematurity, including longer term developmental complications at 18-24 months.

The hypothesis is that milking the umbilical cord before cutting the cord will lead to a higher hemoglobin concentration and decrease the need for blood transfusions in extremely preterm neonates compared to the current standard of immediately clamping the umbilical cord.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Milking the umbilical cord before cord clamping
N/A

Detailed Description

Eligible infants include singleton infants born between 24 and 27 6/7 weeks gestation who do not have congenital anomalies.

Study Design

Study Type:
Interventional
Actual Enrollment :
59 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Milking the Umbilical Cord for Extreme Preterm Infants
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cord Milking

Infant receiving cord milking intervention before umbilical cord clamped.

Procedure: Milking the umbilical cord before cord clamping
The procedure will involve positioning the neonate below the level of the placenta and milking approximately 20cm of umbilical cord three times over 10-20 seconds total from the placental end to the neonate. The cord will then be clamped and the neonate handed to the awaiting medical team for routine care of a premature infant.

No Intervention: Immediate Cord Clamping

Infant whose umbilical cord is immediately clamped after delivery.

Outcome Measures

Primary Outcome Measures

  1. To evaluate and compare hemoglobin and hematocrit concentrations in extremely low birth weight infants (ELVW) after cord milking intervention to ELBW infants receiving immediate cord clamping [Within 4 hour of birth]

  2. To evaluate and compare the incidence and numbers of blood transfusions after cord milking [Prior to initial infant discharge]

Secondary Outcome Measures

  1. To evaluate and compare blood pressure after intervention and need for support medications [For first seven days of life]

  2. To evaluate and compare the incidence of hyperbilirubinemia and length of phototherapy [Three weeks]

    Highest bilirubin or maximum at 120 hours of life, plus total days of phototherapy.

  3. To evaluate the incidence of complications of prematurity in the study and control groups [Until 3 years corrected gestational age]

  4. To evaluate long term outcomes of prematurity in both groups in a follow-up study [Until 3 years corrected gestational age]

  5. To compare the difference in hemoglobin and hematocrit from umbilical cord blood [Within 4 hours of birth]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • pregnant women/child pairs with infants born at an estimated gestation age between 24 0/7 and 27 6/7 weeks based on best estimate made by last menstrual period or ultrasound

  • informed consent obtained by the pregnant women prior to delivery of the infant.

Exclusion Criteria:
  • pregnancy with a multiple gestation

  • infants with pre- or postnatally diagnosed major congenital anomalies or probable chromosomal abnormalities

  • infants with hydrops fetalis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Louis University, Division of Neonatology, SSM Cardinal Glennon Children's Medical Center Saint Louis Missouri United States 63104
2 Saint Louis University, Division of Neonatology, SSM St. Mary's Health Center Saint Louis Missouri United States 63117

Sponsors and Collaborators

  • St. Louis University

Investigators

  • Principal Investigator: Justin B Josephsen, MD, St. Louis University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Justin Josephsen M.D., Assistant Professor, St. Louis University
ClinicalTrials.gov Identifier:
NCT01666847
Other Study ID Numbers:
  • 21429
First Posted:
Aug 16, 2012
Last Update Posted:
Aug 14, 2019
Last Verified:
Aug 1, 2019
Keywords provided by Justin Josephsen M.D., Assistant Professor, St. Louis University

Study Results

No Results Posted as of Aug 14, 2019